Patient Perspectives on Living With Severe Prurigo Nodularis
Because of a paucity of qualitative research on prurigo nodularis (PN), the symptoms and impacts of PN that are most important to patients are poorly understood. To explore patients' perspectives on their PN symptoms and to understand the impacts of the condition. One-on-one qualitative telepho...
Saved in:
Published in: | JAMA dermatology (Chicago, Ill.) Vol. 159; no. 11; p. 1205 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
01-11-2023
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Because of a paucity of qualitative research on prurigo nodularis (PN), the symptoms and impacts of PN that are most important to patients are poorly understood.
To explore patients' perspectives on their PN symptoms and to understand the impacts of the condition.
One-on-one qualitative telephone interviews were held with English-speaking US adults aged 18 years or older with a confirmed diagnosis of PN, severe pruritus, and moderate to severe sleep disturbance. Participants were recruited via patient associations, patient panels, and social media posts. Interviews took place between September 10, 2020, and March 16, 2021.
The main symptoms of PN and their impacts on quality of life were identified by content analysis of deidentified interview transcripts.
A total of 21 adults with PN (mean [SD] age, 53.1 [11.8] years; 15 [71%] female; 2 African American or Black patients [10%], 1 Asian patient [5%], and 18 White patients [86%]; of these, 1 patient [ 5%] had Hispanic or Latino ethnicity) participated in the interviews. All participants reported itch, pain associated with PN, bleeding or scabbing, and dry skin. Other frequently reported symptoms included lumps or bumps (95%), having a crust on the skin (95%), burning (90%), stinging (90%), lesions or sores (86%), skin discoloration (86%), and raw skin (81%). Of the 17 participants who indicated what their worst symptoms were, 15 (88%) identified itching as the worst or 1 of the worst symptoms. The most frequently reported impacts of PN for quality of life were changes in sleep (100%), daily life (100%), feelings or mood (95%), relationships (95%), social life (81%), and work or school (71%). Overall, the worst impact of PN was its association with impaired feelings or mood.
This qualitative study suggests the importance of itching, sleep disturbance, and other symptoms and impacts of PN. This information can be used to guide end point selection in clinical trials and to inform patient-centric decision-making in clinical practice. |
---|---|
AbstractList | Because of a paucity of qualitative research on prurigo nodularis (PN), the symptoms and impacts of PN that are most important to patients are poorly understood.
To explore patients' perspectives on their PN symptoms and to understand the impacts of the condition.
One-on-one qualitative telephone interviews were held with English-speaking US adults aged 18 years or older with a confirmed diagnosis of PN, severe pruritus, and moderate to severe sleep disturbance. Participants were recruited via patient associations, patient panels, and social media posts. Interviews took place between September 10, 2020, and March 16, 2021.
The main symptoms of PN and their impacts on quality of life were identified by content analysis of deidentified interview transcripts.
A total of 21 adults with PN (mean [SD] age, 53.1 [11.8] years; 15 [71%] female; 2 African American or Black patients [10%], 1 Asian patient [5%], and 18 White patients [86%]; of these, 1 patient [ 5%] had Hispanic or Latino ethnicity) participated in the interviews. All participants reported itch, pain associated with PN, bleeding or scabbing, and dry skin. Other frequently reported symptoms included lumps or bumps (95%), having a crust on the skin (95%), burning (90%), stinging (90%), lesions or sores (86%), skin discoloration (86%), and raw skin (81%). Of the 17 participants who indicated what their worst symptoms were, 15 (88%) identified itching as the worst or 1 of the worst symptoms. The most frequently reported impacts of PN for quality of life were changes in sleep (100%), daily life (100%), feelings or mood (95%), relationships (95%), social life (81%), and work or school (71%). Overall, the worst impact of PN was its association with impaired feelings or mood.
This qualitative study suggests the importance of itching, sleep disturbance, and other symptoms and impacts of PN. This information can be used to guide end point selection in clinical trials and to inform patient-centric decision-making in clinical practice. |
Author | Puelles, Jorge Piketty, Christophe Rodriguez, Danielle Dias-Barbosa, Carla Jabbar Lopez, Zarif K Kwatra, Shawn G Zeng, Fanyang |
Author_xml | – sequence: 1 givenname: Danielle surname: Rodriguez fullname: Rodriguez, Danielle organization: Evidera, Seattle, Washington – sequence: 2 givenname: Shawn G surname: Kwatra fullname: Kwatra, Shawn G organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland – sequence: 3 givenname: Carla surname: Dias-Barbosa fullname: Dias-Barbosa, Carla organization: Evidera, Ivry-sur-Seine, France – sequence: 4 givenname: Fanyang surname: Zeng fullname: Zeng, Fanyang organization: Evidera, Bethesda, Maryland – sequence: 5 givenname: Zarif K surname: Jabbar Lopez fullname: Jabbar Lopez, Zarif K organization: Galderma, Zug, Switzerland – sequence: 6 givenname: Christophe surname: Piketty fullname: Piketty, Christophe organization: Galderma, Zug, Switzerland – sequence: 7 givenname: Jorge surname: Puelles fullname: Puelles, Jorge organization: Galderma, Zug, Switzerland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37728897$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j9lKw0AYRgdRbK19hTIvkDpbZgFvpLhB0ICKl2WS_FOnZGNmEvDtLajfzbk4cOC7Quf90ANCG0q2lBB6c7SdbSB0Ng3tlhHGt5zl9AwtGZU6k0SLBVrHeCSnaUIEp5dowZViWhu1RLelTR76hEsIcYQ6-RkiHnpc-Nn3B_zp0xd-gxkC4DJMwR8G_DI0U2uDj9fowtk2wvqPK_TxcP--e8qK18fn3V2RWSFZyupKksoJY5QCa6Q0VnCmmpOsHTU5ECOYZk3tpKuMoYpSXQmXm1pz56hkbIU2v91xqjpo9mPwnQ3f-_8b7AcB_U1j |
CitedBy_id | crossref_primary_10_1111_jdv_20102 crossref_primary_10_1007_s10787_024_01436_9 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1001/jamadermatol.2023.3251 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2168-6084 |
ExternalDocumentID | 37728897 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 0R~ 4.4 53G AAWTL ABJNI ACGFS ADBBV AENEX AFOSN AHMBA ALMA_UNASSIGNED_HOLDINGS AMJDE ANMPU BCGUY BRYMA C45 CGR CUY CVF EBD EBS ECM EIF EMOBN EX3 NPM OB3 OBH OGROG OHH OVD PQQKQ RAJ SV3 TEORI WOW |
ID | FETCH-LOGICAL-a462t-cb60bf49977ea9669a4327da46cf195e094282dcf6fb9917118b4f59c83ff1622 |
IngestDate | Sat Nov 02 12:21:28 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a462t-cb60bf49977ea9669a4327da46cf195e094282dcf6fb9917118b4f59c83ff1622 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC10512162 |
PMID | 37728897 |
ParticipantIDs | pubmed_primary_37728897 |
PublicationCentury | 2000 |
PublicationDate | 2023-11-01 |
PublicationDateYYYYMMDD | 2023-11-01 |
PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | JAMA dermatology (Chicago, Ill.) |
PublicationTitleAlternate | JAMA Dermatol |
PublicationYear | 2023 |
SSID | ssj0000800431 |
Score | 2.4843311 |
Snippet | Because of a paucity of qualitative research on prurigo nodularis (PN), the symptoms and impacts of PN that are most important to patients are poorly... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 1205 |
SubjectTerms | Adult Ethnicity Female Humans Male Middle Aged Pain Prurigo - diagnosis Prurigo - drug therapy Pruritus - drug therapy Quality of Life Skin |
Title | Patient Perspectives on Living With Severe Prurigo Nodularis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37728897 |
Volume | 159 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LSwMxEA6tQvEivt-Sg7eyZZNssyl4EW0RtCI-ULxIdjeBQt0V2-Lfd_LYbbUoevASygbSZufrZL7JPBA66sARSxIeBVnSjoMoFWEgtYKBUBpqTVliS2yc38ZXj-KsG3VrtbK12vTZv0oanoGsTebsH6RdLQoP4DPIHEaQOoy_kvu1K5RqQ9t9FqW9EbgcWNfBg_G73irYlmpev02AmxfNqyIzwaiD0SdLFbRxMzN6e-zKNJnrXhe3YfXKcNia8SLcFBksNXHuaJe2Pqwgc_Eux7adkSkP_Z5P23mdDeQoMDcexUj66JNhdUw8KaeGeqCupD9fvXuCMp-nZ08Xq8Yo4SLgoWsEV-lcXwbcg4vMqFBCbR72vG6f9hQoN98yX9hi1JWsnRHu64uVLgPqIISL__159kvN7XKqjupgQRkj-7Rfee6MjQ1mV5lu7ktYzf-mJdQo1_nCWaztcreClj3pwCcOLauopvI11Oj7sIp1dOxBg2dBg4scO9BgAxrsQIM9aHAFmg103-venZ4Hvq1GICNOx0Ga8DDRwHTjWElgux0ZMRpnMJlq0mkrIPzAw7NUc50Ae4iBgiaRbndSwbQmnNJNtJAXudpGWKdcRBFLGEnBjtVaxIJolUkWpqHiku2gLbfv51dXO-W5fCO7387soaUpjvbRooY_pjpA9VE2ObSC-AD6bVd6 |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patient+Perspectives+on+Living+With+Severe+Prurigo+Nodularis&rft.jtitle=JAMA+dermatology+%28Chicago%2C+Ill.%29&rft.au=Rodriguez%2C+Danielle&rft.au=Kwatra%2C+Shawn+G&rft.au=Dias-Barbosa%2C+Carla&rft.au=Zeng%2C+Fanyang&rft.date=2023-11-01&rft.eissn=2168-6084&rft.volume=159&rft.issue=11&rft.spage=1205&rft_id=info:doi/10.1001%2Fjamadermatol.2023.3251&rft_id=info%3Apmid%2F37728897&rft_id=info%3Apmid%2F37728897&rft.externalDocID=37728897 |